1 the applicant, csl limited ("csl"), seeks an interlocutory injunction to restrain the respondent, glaxosmithkline australia pty ltd ("gska"), from making certain representations concerning gardasil, a vaccine marketed by csl, and cervarix, a vaccine which gska hopes to market in australia in the near future.
2 csl carries on business developing, manufacturing, selling and supplying in australia plasma products, antivenoms and human vaccines.
rofe solicitor for the respondent: deacons date of hearing: 22 september 2006 date of judgment: 3 october 2006 austlii: copyright policy | disclaimers | privacy policy | feedback url: http://www.austlii.edu.au/au/cases/cth/fca/2006/1301.html